Endo Pharmaceuticals Drives Growth in Pain Management with Acquisition of Penwest
By Heather Cartwright
Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)
Published: 21 Sep-2010
DOI: 10.3833/pdr.v2010.i7.1374 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Endo Pharmaceuticals has acquired its long-term partner Penwest Pharmaceuticals, in a deal valued at US$168 M that will enable it to drive growth in pain management...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018